Like AHDS patients, MCT8/OATP1C1 dko mice show locomotor deficits and peripheral hyperthyroidism, making these mice a good model to evaluate novel pharmacological treatments for AHDS. This evidence concerns the gene SLC16A2 and Allan-Herndon-Dudley syndrome.